Literature DB >> 28285651

Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women.

Kati Mokkala1, Outi Pellonperä2, Henna Röytiö3, Pirkko Pussinen4, Tapani Rönnemaa5, Kirsi Laitinen3.   

Abstract

BACKGROUND: Increased intestinal permeability with subsequent metabolic endotoxemia, i.e., elevated circulating levels of bacterial lipopolysaccharide, LPS, has been introduced as a novel initiator of obesity related metabolic disturbances in non-pregnant individuals. The objective was to investigate the extent to which intestinal permeability, measured by serum zonulin concentration, is related to metabolic endotoxemia and metabolic risk markers in overweight pregnant women.
METHODS: This was a cross-sectional study including 100 pregnant overweight women in early pregnancy. Serum zonulin was analyzed using ELISA, and markers for metabolic endotoxemia (LPS), inflammation (high-sensitive C-reactive protein and glycoprotein acetylation GlyA), glucose metabolism (fasting glucose and insulin), and lipid metabolism were measured.
RESULTS: Higher serum zonulin concentration associated positively with LPS (P=0.02), inflammatory markers (P<0.001), insulin (P<0.001), insulin resistance (P<0.001), and triglycerides (P=0.001), and negatively with insulin sensitivity (P=0.001) (ANOVA with Tukey's corrections or Kruskal-Wallis nonparametric test with Bonferroni correction for zonulin quartiles). All the observed associations were confirmed (P<0.015) in a linear regression model adjusted with potential confounding factors. Both LPS and GlycA showed positive relationship with insulin resistance, serum insulin, triglycerides, total and LDL-cholesterol and negative relationship with insulin sensitivity (P≤0.03) in the univariate linear regression. Positive relationship was also found between LPS and HDL-cholesterol (P=0.03).
CONCLUSIONS: Our findings suggest that increased serum zonulin concentration, i.e., increased intestinal permeability, contributes to metabolic endotoxemia, systemic inflammation, and insulin resistance in overweight pregnant women. By reinforcing intestinal barrier, it may be possible to manipulate maternal metabolism during pregnancy with subsequent health benefits.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intestinal permeability; Low grade inflammation; Metabolic endotoxemia; Overweight; Pregnancy

Mesh:

Substances:

Year:  2017        PMID: 28285651     DOI: 10.1016/j.metabol.2016.12.015

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  24 in total

Review 1.  Leaky gut: mechanisms, measurement and clinical implications in humans.

Authors:  Michael Camilleri
Journal:  Gut       Date:  2019-05-10       Impact factor: 23.059

2.  Prediction of gestational diabetes mellitus and perinatal outcomes by plasma zonulin levels.

Authors:  Serkan Oral; Sebahattin Celik; Yasam Kemal Akpak; Hakan Golbasi; Burak Bayraktar; Gokhan Unver; Sami Sahin; Nazan Yurtcu; Canan Soyer Caliskan
Journal:  Arch Gynecol Obstet       Date:  2022-08-22       Impact factor: 2.493

3.  Diabetes-associated alterations in the cecal microbiome and metabolome are independent of diet or environment in the UC Davis Type 2 Diabetes Mellitus Rat model.

Authors:  Brian D Piccolo; James L Graham; Kimber L Stanhope; Intawat Nookaew; Kelly E Mercer; Sree V Chintapalli; Umesh D Wankhade; Kartik Shankar; Peter J Havel; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-07-17       Impact factor: 4.310

4.  Maternal diet during pregnancy and intestinal markers are associated with early gut microbiota.

Authors:  M Selma-Royo; I García-Mantrana; M Calatayud; A Parra-Llorca; C Martínez-Costa; M C Collado
Journal:  Eur J Nutr       Date:  2020-07-29       Impact factor: 5.614

5.  Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota.

Authors:  Carolina Serena; Victoria Ceperuelo-Mallafré; Noelia Keiran; Maria Isabel Queipo-Ortuño; Rosa Bernal; Ricardo Gomez-Huelgas; Mireia Urpi-Sarda; Mónica Sabater; Vicente Pérez-Brocal; Cristina Andrés-Lacueva; Andres Moya; Francisco J Tinahones; Jose Manuel Fernández-Real; Joan Vendrell; Sonia Fernández-Veledo
Journal:  ISME J       Date:  2018-02-12       Impact factor: 10.302

6.  Fecal zonulin is elevated in Crohn's disease and in cigarette smokers.

Authors:  Karin Malíčková; Irena Francová; Milan Lukáš; Martin Kolář; Eva Králíková; Martin Bortlík; Dana Ďuricová; Lenka Štěpánková; Kamila Zvolská; Alexandra Pánková; Tomáš Zima
Journal:  Pract Lab Med       Date:  2017-09-23

Review 7.  Potential Prebiotic Properties of Nuts and Edible Seeds and Their Relationship to Obesity.

Authors:  Clara S A Sugizaki; Maria Margareth V Naves
Journal:  Nutrients       Date:  2018-11-03       Impact factor: 5.717

Review 8.  GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.

Authors:  Margery A Connelly; James D Otvos; Irina Shalaurova; Martin P Playford; Nehal N Mehta
Journal:  J Transl Med       Date:  2017-10-27       Impact factor: 5.531

9.  Serum Zonulin and Endotoxin Levels in Exceptional Longevity versus Precocious Myocardial Infarction.

Authors:  Pedro Carrera-Bastos; Óscar Picazo; Maelán Fontes-Villalba; Helios Pareja-Galeano; Staffan Lindeberg; Manuel Martínez-Selles; Alejandro Lucia; Enzo Emanuele
Journal:  Aging Dis       Date:  2018-04-01       Impact factor: 6.745

10.  Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 - secondary analysis of a randomized controlled trial.

Authors:  Mikael S Huhtala; Kristiina Tertti; Juuso Juhila; Timo Sorsa; Tapani Rönnemaa
Journal:  BMC Pregnancy Childbirth       Date:  2020-07-11       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.